The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Result of AGM

3 Jun 2008 12:11

RNS Number : 8438V
Advanced Medical Solutions Grp PLC
03 June 2008
 



For immediate release 

June  2008

Advanced Medical Solutions Group plc 

("AMS" or "the Company")

Result of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, held its Annual General Meeting this morning at which all resolutions put to shareholders were duly passed. 

Don Evans, AMS's Chief Executive Officer, gave a presentation at the AGM, the slides from which will be made available at the Company's website, www.admedsol.com.

For further information, please contact:

Advanced Medical Solutions Group plc

Don Evans, Chief Executive Officer

Mary Tavener, Finance Director

www.admedsol.com

  

Tel: +44 (0) 1606 545508

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court, Mary-Jane Johnson

Landsbanki Securities (UK) Ltd

Shaun DobsonClaes Spang

Tel: +44 (0) 20 7426 9000

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGSSWFFDSASESM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.